Gut Microbiome

Gut Microbiome - Meet Your Inner Ecosystem

• Definition: A complex community of $10^{13}-10^{14}$ microorganisms (bacteria, viruses, fungi, archaea) residing in the gastrointestinal tract. Their collective genetic material is termed the "microbiome".
• Key Phyla (approximate abundance):
  • Firmicutes (~60-80%)
  • Bacteroidetes (~20-40%)
  • Actinobacteria (~1-10%)
  • Proteobacteria (variable, <5% in health)
• Diversity:
  • Alpha diversity: Richness and evenness of species within a single sample.
  • Beta diversity: Extent of similarity or difference in microbial composition between samples.
• Stability/Resilience: The ability of the microbiome to resist change (stability) and return to its baseline state after a disturbance (resilience).
• Factors Influencing Gut Microbiome:
  • Mode of birth: Vaginal (Lactobacillus, Prevotella) vs. C-section (skin flora like Staphylococcus).
  • Diet: High fiber promotes diversity; high fat/sugar can alter balance.
  • Antibiotics: Can cause short or long-term dysbiosis, reducing diversity.
  • Age: Colonization starts at birth, diversifies through infancy, stabilizes in adulthood, may decline in diversity in the elderly.
  • Host genetics: Influences immune interaction with microbes.
  • Geography & Lifestyle.

⭐ The Firmicutes/Bacteroidetes (F/B) ratio is a frequently discussed biomarker. An elevated F/B ratio is often observed in obesity, but its interpretation is complex and context-dependent. It is not a standalone diagnostic marker but an area of active research for its potential role in metabolic health and disease.

Gut Microbiome - Functions & Favours

The gut microbiome has crucial physiological roles:

• Metabolic Functions:

  • SCFA Production: $Dietary Fiber \xrightarrow{Microbiota} SCFAs$ (📌 BAP: Butyrate, Acetate, Propionate)
    • Butyrate: Colonocyte fuel; anti-inflammatory.
    • Acetate: Cholesterol synthesis, lipogenesis.
    • Propionate: Hepatic gluconeogenesis, satiety.
  • Vitamin Synthesis: Vit K, B vitamins (B12, folate, biotin).
  • Bile Acid Metabolism: Primary $\rightarrow$ Secondary bile acids (e.g., deoxycholic acid).
  • Xenobiotic & Drug Metabolism: Detoxification, drug processing.

• Protective Functions:

  • Colonization Resistance: Against pathogens (e.g., C. difficile); nutrient competition.
  • Gut Barrier Integrity: Enhances mucus layer, tight junctions.

• Immune System Development & Modulation:

  • Immune Education: Matures innate & adaptive immunity.
  • IgA Production: ↑ Secretory IgA (sIgA).
  • Treg Induction: Promotes regulatory T cells (Tregs).
  • Cytokine Balance: Modulates pro/anti-inflammatory cytokines.

⭐ Butyrate, a key SCFA produced by gut bacteria from dietary fiber, is the preferred energy source for colonocytes and exerts potent anti-inflammatory effects.

Gut Microbiome - Dysbiosis & Drama

Dysbiosis: Imbalance in gut microbial composition, diversity, or function.

• Mechanisms:
  • Loss of beneficial microbes (e.g., Lactobacillus).
  • Pathobiont overgrowth.
  • Reduced microbial diversity.

Associated Diseases:

• IBD (Crohn's, UC): ↓Faecalibacterium prausnitzii.
• IBS: Variable dysbiosis.
• Obesity & Metabolic Syndrome: Altered F/B ratio, ↓diversity.
• T2DM: Links to insulin resistance.
• C. difficile Infection (CDI): Post-antibiotic.
• Allergies/Asthma: Immune dysregulation.
• Colorectal Cancer (CRC): ↑Fusobacterium nucleatum.
• NAFLD/NASH: Gut-liver axis.
• Gut-Brain Axis Disorders (Autism, Depression, Anxiety).

Modulation Strategies:

• Probiotics: Live beneficial microbes.
• Prebiotics: e.g., inulin, FOS (fuel good bacteria).
• Synbiotics: Pro + Prebiotics.
• Diet: Fiber-rich.
• FMT: For recurrent CDI (efficacy >90%).

⭐ Fecal Microbiota Transplantation (FMT) demonstrates high efficacy (often >90%) in treating recurrent Clostridioides difficile infection, a condition frequently precipitated by antibiotic-induced dysbiosis.

High-Yield Points - ⚡ Biggest Takeaways

• Gut microbiome: Predominantly anaerobic bacteria; Firmicutes & Bacteroidetes are dominant.
• Functions: Vitamin K & B synthesis, SCFA production (butyrate), immune modulation, colonization resistance.
• Dysbiosis linked to IBD, obesity, metabolic syndrome.
• Probiotics (live microbes) & prebiotics (substrates) modulate microbiome.
• FMT effective for recurrent C. difficile infection.
• Diet is a major modulator of gut microbiome.
• Butyrate (an SCFA) is key energy for colonocytes; anti-inflammatory効果 (kouka - effect/efficacy, but sticking to English as per general style).